- Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that the second patient (EA2) with non-active secondary progressive multiple sclerosis (SPMS) receiving intranasal foralumab had shown additional clinical improvements since their last reported improvement in September 2022.
- The improvements were measured by the Expanded Disability Status Scale (EDSS), an FDA – recognized standard clinical outcome assessment measuring neural network functioning.
- Related: Tiziana Life Sciences Shares Jump After Multiple Sclerosis Data From Second Patient.
- Before foralumab treatment, EA2’s non-active SPMS disability had progressed, and EDSS worsened from 3.5 in 2018 to 6.0 in 2021 despite ocrelizumab therapy that was discontinued in 2021.
- In September 2022, 8 months after starting treatment with nasal foralumab, EA2 could walk 100 meters without a cane. EDSS score improved from 6.0 to 5.5. EA2’s pyramidal score remained stable during this time. In December 2022, 11 months after starting treatment with intranasal foralumab, EA2 could walk 200 meters without a cane, resulting in an even greater improvement in EDSS; with EDSS falling from a score of 5.5 to 5.0. EA2’s pyramidal score continued to remain stable.
- Price Action: TLSA shares are up 1.84% at $0.61 on the last check Tuesday.
Tiziana Life Sciences Posts Additional Clinical Improvements In Second Patient with Multiple Sclerosis
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that the second patient (EA2) with non-active secondary progressive multiple sclerosis (SPMS) receiving…
Related Posts
TerrAscend To Secure $15M Via Private Placements
TerrAscend Corp. (OTCQX: TRSSF) (CSE:TER) announced its intention to complete two concurrent private placements for total gross proceeds of approximately $15 million. The company has received indicative orders of approximately $15 million.
Mirati Therapeutics Shares Move Higher, FDA Website Shows Approval Of Krazati (adagrasib)
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216340
Apparel Retailer Express Files for Bankruptcy; Shuts Some Stores
Express Inc (OTC:EXPR) and subsidiaries file Chapter 11 petitions, signaling a strategic move to optimize operations and strengthen financial position. The retailer plans to shutter 95 stores, including all UpWest outlets, with a commitment of $35 million in new financing. Amidst this restructuring, Express receives $49 million from the IRS and eyes a potential majority stake sale to WHP Global-led consortium.